Page 136 - MemoriaES-Eng

RESEARCH GROUPS

í

í
áé
ó

ñ

íá

é

ó
íííí

PROGRAMME:
Group 5
Asthma

Group Members
Lead Researcher

STAFF MEMBERS
Picado Vallés, César

Martn Robles, Irene Carla
Torres Blanch, Rosa

Contact:
íVennera Trunzo, Ma del Carmen

Servicio de Neumologa Esc. 6-8 Planta 2a ASSOCIATED MEMBERS
Hospital Clinico y Provincial de Barcelona
Alobid, Isam
C/ Villarroel, 170. Barcelona · Phone: (+34) 93 451 09 93 Fernndez Bertolin, Laura
E.mail: [email protected]
Fuentes Prado, Mireya

Guilemany Toste, Jos Mara
Martnez Antn, Mara Asuncin Main lines of research

Molina Molina, Mara
Mullol Miret, Joaquim • Study of the links between upper airway diseases (rhinitis, rhinosinusitis and

Muoz Cano, Rosa nasal polyps) and lower airway diseases (asthma, chronic obstructive pulmo-
Prez Gonzlez, Mara nary disease and bronchiectasis). Relationship between chronic rhinosinusitis

Pujols Tarres, Laura and asthma severity.

Roca Ferrer, Jordi • Study of the alterations in the regulation of glucocorticoid receptor in the
Serrano Mollar, Ana Mara reduced response to glucocorticoids (glucocorticoid resistance) in inflam-

Torres Blanch, Rosa matory airway diseases (chronic rhinosinusitis, nasal polyposis and asthma).
Valero Santiago, Antonio 13
• Study of the role of the cyclooxygenase pathaway of arachidonic acid metabo- 20
Xaubet Mir, Antonio
T
lism in the pathophysiology of airway inflammation (chronic rhinosinusitis, R
asthma), and in the airways remodelling and lung fibrosis.
PO
E
• L R
Study of the mechanisms involved in non-steroidal antiinflammatory drugs A
intolerance in asthma.
NU
N
• Severe asthma: study of the efficacy of the new biologic therapies (omali- A
/
zumab).
ES
ER
• New therapies: 6.1 In asthma (agonists of EP2 receptor of prostaglandin E2). B
CI
6.2 Transplantation of type II alveolar cells in the treatment of lung fibrosis

136